2021
DOI: 10.1007/s12250-020-00341-z
|View full text |Cite
|
Sign up to set email alerts
|

Development of A MERS-CoV Replicon Cell Line for Antiviral Screening

Abstract: Middle East respiratory syndrome coronavirus (MERS-CoV) is the causative agent of a severe respiratory disease with a high mortality of ~ 35%. The lack of approved treatments for MERS-CoV infection underscores the need for a user-friendly system for rapid drug screening. In this study, we constructed a MERS-CoV replicon containing the Renilla luciferase ( Rluc ) reporter gene and a stable luciferase replicon-carrying cell line. Using this cell line, we showed that … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

2
3

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 23 publications
0
4
0
Order By: Relevance
“… 38 N/A MERS-CoV-NP TCTGTCCTGTCTCCGCCAAT Chen et al. 38 N/A human IFNβ CTTGGATTCCTACAAAGAAGCAGC This paper N/A R-human IFNβ TCCTCCTTCTGGAACTGCTGCA This paper N/A F-human ISG15 CTCTGAGCATCCTGGTGAGGAA This paper N/A R-human ISG15 AAGGTCAGCCAGAACAGGTCGT This paper N/A F-human GAPDH ACAACTTTGGTATCGTGGAAGG This paper N/A R-human GAPDH GCCATCACGCCACAGTTTC This paper N/A CoV-FWD3: GGTTGGGAYTAYCCHAARTGTGA Latinne et al. 40 N/A CoV-RVS3: CCATCATCASWYRAATCATCATA Latinne et al.…”
Section: Methodsmentioning
confidence: 99%
“… 38 N/A MERS-CoV-NP TCTGTCCTGTCTCCGCCAAT Chen et al. 38 N/A human IFNβ CTTGGATTCCTACAAAGAAGCAGC This paper N/A R-human IFNβ TCCTCCTTCTGGAACTGCTGCA This paper N/A F-human ISG15 CTCTGAGCATCCTGGTGAGGAA This paper N/A R-human ISG15 AAGGTCAGCCAGAACAGGTCGT This paper N/A F-human GAPDH ACAACTTTGGTATCGTGGAAGG This paper N/A R-human GAPDH GCCATCACGCCACAGTTTC This paper N/A CoV-FWD3: GGTTGGGAYTAYCCHAARTGTGA Latinne et al. 40 N/A CoV-RVS3: CCATCATCASWYRAATCATCATA Latinne et al.…”
Section: Methodsmentioning
confidence: 99%
“…Nluc expression and subgenomic N RNA production were measured in BHK-21 cells transfected with the plasmids. The MERS-CoV replicon was generated in our previous study by modified Nluc replacement [ 17 ].…”
Section: Methodsmentioning
confidence: 99%
“…This potentially allows the screening for antiviral compounds that target viral replication in cellulo (8). Prior to SARS-CoV-2, replicon systems had been created for other coronaviruses, such as SARS-CoV (sometimes called SARS-CoV-1) as well as the Middle East respiratory syndrome-related coronavirus (MERS-CoV) (9, 10).…”
Section: Introductionmentioning
confidence: 99%